As the global economy mends, the 2021 growth of Antibiotic API will have significant change from previous year. According to our (LP Information) latest study, the global Antibiotic API market size is USD million in 2022 from USD 5319.6 million in 2021, with a change of % between 2021 and 2022. The global Antibiotic API market size will reach USD 4837.3 million in 2028, growing at a CAGR of -1.3% over the analysis period.
The United States Antibiotic API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibiotic API market, reaching US$ million by the year 2028. As for the Europe Antibiotic API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibiotic API players cover UNITED LABORATORIES, North China Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, and Centrient Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oral Medicine
Injection Medicine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL